Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial.
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
Low-dose aspirin started in the first-trimester has been associated with a decrease of
preeclampsia, fetal growth restriction and preterm birth in high-risk pregnancies. Multiple
pregnancies are considered a risk factor for all those adverse outcomes. The main objective
of the current trial is to evaluate whether a dose of 80 mg of aspirin is associated with an
improvement of birthweight compared to placebo in twin pregnancies.
Phase:
Phase 2
Details
Lead Sponsor:
Centre Hospitalier Universitaire de Québec, CHU de Québec CHU de Quebec-Universite Laval